1-Year Old Biotech Goldfinch Steals AstraZeneca R&D Exec for CEO Post Post author:Sam Post published:December 5, 2017 Post category:BioPharma Goldfinch Bio continues to expand its leadership team. Source: BioSpace You Might Also Like Rubius Therapeutics Raises $100 Million in Crossover Financing February 28, 2018 Consolidation Could Be Coming to Pharma Industry March 14, 2018 Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017
Merck & Co.'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer, Eli Lilly and Roche's Failed June 26, 2017
